Summary by Moomoo AI
On April 24, 2024, bluebird bio, Inc. received a notice from The Nasdaq Stock Market LLC indicating the company is not in compliance with Nasdaq Listing Rule 5250(c)(1) due to a delay in filing its Annual Report on Form 10-K for the year ended December 31, 2023. The company has until June 24, 2024, to submit a plan to regain compliance and may be granted an extension until October 14, 2024, to file the report. The delay is attributed to the need to restate financial statements for the year ended December 31, 2022, and unaudited financial information for the first three quarters of 2023 and 2022. The restatements are related to the identification of embedded leases and the treatment of non-lease components in lease agreements, which are not expected to impact...Show More